We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

DSM Announces License Agreement with Amgen

News   Jan 15, 2013

 
DSM Announces License Agreement with Amgen
 
 
 

RELATED ARTICLES

The Fluid That Feeds Tumor Cells

News

The substance that bathes tumors in the body is quite different from the medium used to grow cancer cells in the lab, biologists report.

READ MORE

3D Heart Printed Using Patient's Own Tissue

News

The engineered heart completely matches the immunological, cellular, biochemical and anatomical properties of the patient.

READ MORE

Cancers “Change Spots” to Dodge Immunotherapy

News

Cancers can make themselves harder for new immunotherapies to see by ‘changing their spots’ – and switching off a key molecule on the surface of cells that is otherwise recognized by treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE